These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
588 related articles for article (PubMed ID: 25604309)
1. Novel poly (ADP-ribose) polymerase inhibitor, AZD2281, enhances radiosensitivity of both normoxic and hypoxic esophageal squamous cancer cells. Zhan L; Qin Q; Lu J; Liu J; Zhu H; Yang X; Zhang C; Xu L; Liu Z; Cai J; Ma J; Dai S; Tao G; Cheng H; Sun X Dis Esophagus; 2016 Apr; 29(3):215-23. PubMed ID: 25604309 [TBL] [Abstract][Full Text] [Related]
2. Effect of a poly(ADP-ribose) polymerase-1 inhibitor against esophageal squamous cell carcinoma cell lines. Nasuno T; Mimaki S; Okamoto M; Esumi H; Tsuchihara K Cancer Sci; 2014 Feb; 105(2):202-10. PubMed ID: 24219164 [TBL] [Abstract][Full Text] [Related]
3. Bortezomib sensitizes esophageal squamous cancer cells to radiotherapy by suppressing the expression of HIF-1α and apoptosis proteins. Wang D; Qin Q; Jiang QJ; Wang DF J Xray Sci Technol; 2016 Apr; 24(4):639-46. PubMed ID: 27080362 [TBL] [Abstract][Full Text] [Related]
4. Hypoxia Potentiates the Radiation-Sensitizing Effect of Olaparib in Human Non-Small Cell Lung Cancer Xenografts by Contextual Synthetic Lethality. Jiang Y; Verbiest T; Devery AM; Bokobza SM; Weber AM; Leszczynska KB; Hammond EM; Ryan AJ Int J Radiat Oncol Biol Phys; 2016 Jun; 95(2):772-81. PubMed ID: 27020103 [TBL] [Abstract][Full Text] [Related]
5. Effect of sinomenine hydrochloride on radiosensitivity of esophageal squamous cell carcinoma cells. Fu S; Jin L; Gong T; Pan S; Zheng S; Zhang X; Yang T; Sun Y; Wang Y; Guo J; Hui B; Zhang X Oncol Rep; 2018 Apr; 39(4):1601-1608. PubMed ID: 29393484 [TBL] [Abstract][Full Text] [Related]
6. STAT3 inhibitor stattic enhances radiosensitivity in esophageal squamous cell carcinoma. Zhang Q; Zhang C; He J; Guo Q; Hu D; Yang X; Wang J; Kang Y; She R; Wang Z; Li D; Huang G; Ma Z; Mao W; Zhou X; Xiao C; Sun X; Ma J Tumour Biol; 2015 Mar; 36(3):2135-42. PubMed ID: 25492480 [TBL] [Abstract][Full Text] [Related]
7. Sunitinib modulates the radiosensitivity of esophageal squamous cell carcinoma cells in vitro. Ding YQ; Zhu HC; Chen XC; Sun XC; Yang X; Qin Q; Zhang H; Yang Y; Yang YH; Gao L; Luo JD; Zhou XF Dis Esophagus; 2016 Nov; 29(8):1144-1151. PubMed ID: 26542732 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of PARP-1 by olaparib (AZD2281) increases the radiosensitivity of a lung tumor xenograft. Senra JM; Telfer BA; Cherry KE; McCrudden CM; Hirst DG; O'Connor MJ; Wedge SR; Stratford IJ Mol Cancer Ther; 2011 Oct; 10(10):1949-58. PubMed ID: 21825006 [TBL] [Abstract][Full Text] [Related]
9. Nutlin-3, an Antagonist of MDM2, Enhances the Radiosensitivity of Esophageal Squamous Cancer with Wild-Type p53. He T; Guo J; Song H; Zhu H; Di X; Min H; Wang Y; Chen G; Dai W; Ma J; Sun X; Ma J Pathol Oncol Res; 2018 Jan; 24(1):75-81. PubMed ID: 28341911 [TBL] [Abstract][Full Text] [Related]
11. Radiosensitization with an inhibitor of poly(ADP-ribose) glycohydrolase: A comparison with the PARP1/2/3 inhibitor olaparib. Gravells P; Neale J; Grant E; Nathubhai A; Smith KM; James DI; Bryant HE DNA Repair (Amst); 2018 Jan; 61():25-36. PubMed ID: 29179156 [TBL] [Abstract][Full Text] [Related]
13. PARP inhibitor olaparib sensitizes cholangiocarcinoma cells to radiation. Mao Y; Huang X; Shuang Z; Lin G; Wang J; Duan F; Chen J; Li S Cancer Med; 2018 Apr; 7(4):1285-1296. PubMed ID: 29479816 [TBL] [Abstract][Full Text] [Related]
14. Radiosensitization with combined use of olaparib and PI-103 in triple-negative breast cancer. Jang NY; Kim DH; Cho BJ; Choi EJ; Lee JS; Wu HG; Chie EK; Kim IA BMC Cancer; 2015 Mar; 15():89. PubMed ID: 25884663 [TBL] [Abstract][Full Text] [Related]
15. BLM helicase inhibition synergizes with PARP inhibition to improve the radiosensitivity of olaparib resistant non-small cell lung cancer cells by inhibiting homologous recombination repair. Kong Y; Xu C; Sun X; Sun H; Zhao X; He N; Ji K; Wang Q; Du L; Wang J; Zhang M; Liu Y; Wang Y; Liu Q Cancer Biol Med; 2021 Dec; 19(8):1150-71. PubMed ID: 34846107 [TBL] [Abstract][Full Text] [Related]
16. Talazoparib Is a Potent Radiosensitizer in Small Cell Lung Cancer Cell Lines and Xenografts. Laird JH; Lok BH; Ma J; Bell A; de Stanchina E; Poirier JT; Rudin CM Clin Cancer Res; 2018 Oct; 24(20):5143-5152. PubMed ID: 29945991 [No Abstract] [Full Text] [Related]
17. Small-molecule survivin inhibitor YM155 enhances radiosensitization in esophageal squamous cell carcinoma by the abrogation of G2 checkpoint and suppression of homologous recombination repair. Qin Q; Cheng H; Lu J; Zhan L; Zheng J; Cai J; Yang X; Xu L; Zhu H; Zhang C; Liu J; Ma J; Zhang X; Dai S; Sun X J Hematol Oncol; 2014 Aug; 7():62. PubMed ID: 25139395 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of Parp1 by BMN673 Effectively Sensitizes Cells to Radiotherapy by Upsetting the Balance of Repair Pathways Processing DNA Double-Strand Breaks. Soni A; Li F; Wang Y; Grabos M; Krieger LM; Chaudhary S; Hasan MSM; Ahmed M; Coleman CN; Teicher BA; Piekarz RL; Wang D; Iliakis GE Mol Cancer Ther; 2018 Oct; 17(10):2206-2216. PubMed ID: 29970481 [TBL] [Abstract][Full Text] [Related]
20. Zidovudine, abacavir and lamivudine increase the radiosensitivity of human esophageal squamous cancer cell lines. Chen X; Wang C; Guan S; Liu Y; Han L; Cheng Y Oncol Rep; 2016 Jul; 36(1):239-46. PubMed ID: 27220342 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]